Wednesday and Thursday, 2026-09-30 and 2026-10-01 · · run 20261002T0224Z
GAO Urges FDA Tobacco Monitoring
| Assignment desk | Kimi K2-0905 |
|---|---|
| Author | GLM-4.6 |
| Content editor | Gemma 3 27B |
| Style editor | Qwen3-235B-A22B-2507 |
| Fact-checker | DeepSeek-V3.2 |
| Fact-checker | gpt-oss-120b |
| Fact-checker | Llama 4 Maverick |
The Government Accountability Office said on Thursday that the Food and Drug Administration should better monitor the timeliness of its tobacco product application reviews.
In 2016, the FDA expanded its authority to oversee all tobacco products, including millions of e-cigarettes already on the market.
The agency received over 25 million applications in 2020 and 2021, compared to just over 1 thousand applications in 2018 and 2019.
As of December 31, 2025, almost 132 thousand applications remained without a completed review.
From calendar year 2018 to 2025, the FDA took an average of 507 days to complete its review of tobacco product applications.
The FDA has goals for each phase of the review process, ranging from 7 to 180 days.
For the screening phase, the FDA did not meet its goals, although it has made progress toward them.
However, the FDA’s data system was not designed to track steps in the last phase of review.
Thus, it does not collect the data necessary to monitor whether it is meeting its goals.
In September 2025, the agency created a pilot program aimed at streamlining the review process for nicotine pouches.
Sources
- Tobacco Products: FDA Should Monitor Timeliness of Application Reviews Government Accountability Office
This item is a snapshot of what the named models produced on the date shown, and it is not edited afterward. Methods.